Nicotinic acetylcholine receptor subunit alpha (nAChR α subunit)

Nicotinic acetylcholine receptor subunit alpha refers to one of several homologous protein components that assemble into pentameric ligand-gated ion channels known as nicotinic acetylcholine receptors (nAChRs). These receptors respond to the neurotransmitter acetylcholine by opening a central pore permeable primarily to sodium, potassium, and sometimes calcium ions. There are multiple genes encoding different α-subunits—ten have been identified in mammals—each contributing distinct pharmacological properties when combined into various homo-pentameric or hetero-pentameric complexes. The binding site for ligands is located at the interface between an α-subunit (“principal face”) and a neighboring non-alpha (“complementary face”) subunit. nAChRs play essential roles in both central and peripheral nervous systems by mediating fast synaptic transmission at neuromuscular junctions and modulating neuronal signaling involved in cognition, reward pathways, inflammation control, and more. Dysfunction or dysregulation of specific nAChR α-subunits has been implicated in numerous neurological disorders including Alzheimer’s disease, schizophrenia, addiction syndromes, autoimmune conditions such as myasthenia gravis, among others.

Other names

nAChR alpha subunitNeuronal acetylcholine receptor subunit alphaCHRNA (for specific genes, e.g., CHRNA7 for α7)Acetylcholine receptor, nicotinic, alpha polypeptide

Drugs targeting this molecule act as either agonists or antagonists at the ligand-binding site between adjacent subunits. Agonists like nicotine activate the ion channel to allow cation influx; antagonists block this action. Some drugs are partial agonists or allosteric modulators that alter channel function without directly competing with acetylcholine.